Product Details

Trileptal

Oxcarbazepine
600 mg
Tablet


DIN/PIN/NPN

02242069

Manufacturer

Novartis Pharma Canada Inc.

Formulary Listing Date

2008-06-27  

Unit Price

NA

Amount MOH Pays

NA

Coverage Status

Off-Formulary Interchangeable Exceptional Access Program Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

N03AF02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02242069 Trileptal NA NA
02440733 Jamp-Oxcarbazepine 1.8204 1.8204
02284316 Apo-Oxcarbazepine 1.8204 1.8204
 

LU Clinical Criteria

NO  

EAP Criteria

Therapeutic Class Reimbursement Criteria
Anticonvulsants

Oxcarbazepine

  • Brand(s): Trileptal
  • Dosage Form/Strength: 150 mg, 300 mg, and 600 mg tablet 60 mg/mL

For the treatment of partial seizures in adults and in children aged 6 years and older who have had an inadequate response or intolerance* to at least 3 other formulary agents (prior or current use) including carbamazepine.

*Intolerance must be described in detail.

Warning: Life-threatening dermatological reactions, including Stevens Johnson Syndrome and toxic epidermal necrolysis, and multi-organ hypersensitivity reactions have been associated with the use of oxcarbazepine. More information may be found on the Health Canada webpage:
http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/trileptal_hpc-cps_e.html

Duration of Approval: Lifetime

EAP Drug Request Form:

Standard Form for EAP Drug Requests

Product Monograph

View Monograph